These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20274525)

  • 21. General systemic actions of di-isopropyl fluorophosphate (DFP) in cats.
    MODELL W; KROP S
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):400-13. PubMed ID: 20279261
    [No Abstract]   [Full Text] [Related]  

  • 22. The chronic toxicity of di-isopropyl fluorophosphate (DFP) in dogs, monkeys and rats.
    KOELLE GB; GILMAN A
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):435-48. PubMed ID: 20279264
    [No Abstract]   [Full Text] [Related]  

  • 23. Bacteremia following tooth extraction; prevention with penicillin and 3,4-dimethyl-5-sulfanilamide-isoxazole.
    RHOADS PS; SCHRAM WR
    J Lab Clin Med; 1948 Nov; 33(11):1461. PubMed ID: 18890046
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of di-isopropyl fluorophosphate on the action potential of muscle.
    COUTEAUX R; GRUNFEST H
    Science; 1946 Oct; 104(2701):317. PubMed ID: 20998456
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of myasthenia gravis with di-isopropylfluorophosphonate.
    GADDUM JH; WILSON A
    Nature; 1947 May; 159(4046):680. PubMed ID: 20239734
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of cholinesterase by di-isopropyl fluorophosphate, physostigmine and hexaethyl tetraphosphate in the roach.
    Chadwick LE; Hill DL
    J Neurophysiol; 1947 May; 10(3):235-46. PubMed ID: 20239778
    [No Abstract]   [Full Text] [Related]  

  • 27. Diisopropyl fluorophosphate.
    GODLEY LF
    Bull Am Soc Hosp Pharm; 1947; 4(1):4-7. PubMed ID: 20297423
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of di-isopropyl fluorphosphate (DFP) on action potential and cholinesterase of nerve.
    GRUNDFEST H; NACHMANSOHN D; ROTHENBERG MA
    J Neurophysiol; 1947 Mar; 10(2):155-64. PubMed ID: 20291842
    [No Abstract]   [Full Text] [Related]  

  • 29. Stevens-Johnson disease; report of a case.
    GROVE BA; MEISENHELDER E
    Arch Ophthal; 1946 Nov; 36(5):631-4. PubMed ID: 20275771
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of diisopropyl-flurophosphate upon the submaxillary gland.
    BRASSFIELD CR; BIGGINS C; MUSSELMAN MM
    Fed Proc; 1947 Mar; 6(1 Pt 2):80. PubMed ID: 20342506
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic results of a new sulfonamide (2-sulfanilamido-di-methoxy triazin) in urinary tract infections].
    EHRENREICH R; HASCHEK H
    Wien Klin Wochenschr; 1956 Jan; 68(3):45-6. PubMed ID: 13300013
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental studies on 2-sulfanilamido-5-methylpyrimidine].
    HEPDING L; HOFFMANN A; WAHLIG H
    Arzneimittelforschung; 1960 Jun; 10():440-8. PubMed ID: 14401170
    [No Abstract]   [Full Text] [Related]  

  • 33. [6-Sulfanilamido-2,4-dimethylpyrimidine; contribution to sulfonamide therapy].
    KORNER H
    Dtsch Gesundheitsw; 1950 Jun; 5(23):727-8. PubMed ID: 15427471
    [No Abstract]   [Full Text] [Related]  

  • 34. [Curative & preventive treatment of amnionitis with 3,4-dimethyl-5-sulfanilamido-isoxazole].
    MASSANO A; MUSSO G
    Minerva Ginecol; 1959 Apr; 11(8):343-5. PubMed ID: 13666531
    [No Abstract]   [Full Text] [Related]  

  • 35. [2-Sulfanilamido-3-methoxypyrazine. Chemical, physicochemical, biological and therapeutic characteristics].
    ROCCHIETTA S
    Boll Chim Farm; 1961 Apr; 100():279-81. PubMed ID: 13742397
    [No Abstract]   [Full Text] [Related]  

  • 36. Blood levels in relation to dosage of 3,4 dimethyl-5 sulfanilamido-isoxazole (gantrisin) in children with clinical observations.
    PRICE PC; HANSEN AE
    Tex Rep Biol Med; 1951; 9(4):764-79. PubMed ID: 14901327
    [No Abstract]   [Full Text] [Related]  

  • 37. [THERAPEUTIC ACTION OF 2-SULFANILAMIDO-5-METHOXYPYRIMIDINE ON SUBACUTE AND CHRONIC CHOLECYSTITIS].
    VALENTI G; BELLODI G
    Policlinico Prat; 1964 Aug; 71():1273-7. PubMed ID: 14192188
    [No Abstract]   [Full Text] [Related]  

  • 38. [Influencing of the tubular function in renal excretion of 4-sulfanilamido-2, 6-dimethylpyrimidine].
    PORTWICH F; BUTTNER H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 229(6):513-9. PubMed ID: 13407769
    [No Abstract]   [Full Text] [Related]  

  • 39. [PHARMACOKINETICS OF 2-SULFANILAMIDO-5-ETHYLPYRIMIDINE IN MAN].
    PLANCHER AC; SALVI G; BACUZZI E
    Farmaco Prat; 1964 Nov; 19():550-9. PubMed ID: 14234089
    [No Abstract]   [Full Text] [Related]  

  • 40. [Sulfapyrimidine in chemotherapy; clinical experiences with 6-sulfanilamido-2,4-dimethylpyrimidin, L 30 of Nordmark and Co..].
    HAUCH HJ; LUDWIG L; MULHENS K
    Z Gesamte Inn Med; 1950 Mar; 5(5-6):159-68. PubMed ID: 15425176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.